Antibacterial activity of freshwater green microalgae from Almaty region

BIO Web of Conferences, 2024

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.1051/bioconf/202410002014
Data confidence 85 high
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The urgent search for new natural bioactive compounds has led to the investigation of freshwater microalgae in the Almaty region for their antibacterial properties. For this purpose, a study was carried out to investigate microalgae cultures from the division of Clorophyta for their potential to produce biologically active compounds (Parachlorella kessleri, Monoraphidium griffithii, Ankistrodesmus falcatus, Nephrochlamys subsolitaria), which also have the potential for wide use in other biotechnological applications. Methanol extracts of 4 strains of microalgae cultures against 11 strains of bacteria were used to evaluate the biological antibacterial activity. Significant antibacterial effects were observed, in particular the methanol extract of P. kessleri showed high activity against B. subtilis, S. aureus and K. pneumoniae; N. subsolitaria showed strong activity against B. subtilis, P. aeruginosa and E. coli. The results of GC/MS analysis confirmed the presence of important bioactive compounds (decamethylcyclopentasiloxane, octamethylcyclotetrasiloxane, hexamethylcyclotrisiloxane) in the microalgae extracts. The data obtained play an important role in the development of microalgae-based antibacterial drugs.